Overview

Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty

Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
Femoral nerve block (FNB) is a first-line analgesic technique for multimodal analgesia after total knee arthroplasty (TKA). Recent studies and meta-analysis indicate that dexmedetomidine combined with local anesthetics for FNB can prolong the analgesic duration, improve the analgesic efficacy, inhibit local inflammatory response, and reduce narcotic consumption. The investigators hypothesize that dexmedetomidine combined with ropivacaine for FNB can also improve functional recovery in aged patients after TKA.
Phase:
Phase 4
Details
Lead Sponsor:
Peking University First Hospital
Collaborator:
Beijing Jishuitan Hospital
Treatments:
Dexmedetomidine